Related Experiment Video
Updated: Jul 19, 2025

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Laryngospasm as an uncommon presentation in a patient with anti-N-methyl-D-aspartate receptor encephalitis: A case
Lu Wang1, Hong-Jun Su1, Guan-Jie Song2
1Department of Neurology, Tianjin Baodi Hospital, Tianjin 301800, China.
Background:
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rare autoimmune disorder. The symptoms of anti-NMDAR encephalitis include behavioral problems, speech problems, psychosis, seizures, and memory deficits, among others. However, laryngospasm is rare. We present the case of a patient with anti-NMDAR antibodies and severe laryngospasms.
Case Summary:
The patient was a 15-year-old female with normal psychomotor development. She was initially admitted to our neurological intensive care unit with seizures. She received anti-epilepsy treatment, and the seizures disappeared. However, 2 wk later, she developed behavioral problems and speech impairment. Then, she developed severe laryngospasms, which were treated with intubation and a tracheotomy. Antibodies against the NMDAR were detected in the patient's cerebrospinal fluid. Therefore, she was diagnosed with anti-NMDAR encephalitis. In addition, she received intravenously administered immunoglobulins, and methylprednisolone was administered. The patient's symptoms gradually improved, and she was discharged from our hospital. Approximately 9 mo later, the patient could speak sentences, walk independently, and carry out activities of daily living independently. Through our case report, we highlighted laryngospasm as an uncommon presentation in patients with anti-NMDAR encephalitis.
Conclusion:
Laryngospasm may be an uncommon clinical manifestation of anti-NMDAR encephalitis.
Insights
Severe laryngospasms, a rare symptom, occurred in a 15-year-old diagnosed with anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis. This case highlights laryngospasm as an uncommon presentation of this autoimmune neurological disorder.
Area of Science:
- Neurology
- Immunology
- Autoimmune Diseases
Background:
- Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a rare autoimmune disorder.
- Commonly presents with behavioral, speech, psychosis, seizure, and memory issues.
- Laryngospasm is an infrequent manifestation.
Observation:
- A 15-year-old female with normal development presented with seizures, behavioral problems, and speech impairment.
- Developed severe laryngospasms requiring intubation and tracheotomy.
- NMDAR antibodies detected in cerebrospinal fluid confirmed the diagnosis.
Findings:
- The patient received immunotherapy (intravenous immunoglobulins and methylprednisolone).
- Symptoms gradually improved, with significant recovery over 9 months.
- Laryngospasm was identified as an uncommon clinical presentation.
Implications:
- Highlights laryngospasm as a potential, albeit rare, symptom of anti-NMDAR encephalitis.
- Suggests considering anti-NMDAR encephalitis in patients presenting with unexplained laryngospasm.
- Emphasizes the importance of early diagnosis and treatment for improved patient outcomes.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
06:19Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Related Concept Videos
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Skeletal Muscle Relaxants: Therapeutic Uses
Antiepileptic Drugs: Glutamate Antagonists
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...